Published online before print December 10, 2007

This Article Full Text (Reprint (PDF)) All Versions of this Article: jlb.0907629v1 83/3/702    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Muroi, M. Articles by Tanamoto, K.-i. Search for Related Content PubMed PubMed Citation Articles by Muroi, M. Articles by Tanamoto, K.-i.

© by The Society for Leukocyte Biology
Journal of Leukocyte Biology, doi:10.1189/jlb.0907629

Received for publication September 13, 2007.
Revised November 9, 2007.
Accepted for publication November 12, 2007.

Article

TRAF6 distinctively mediates MyD88- and IRAK-1-induced activation of NF-B

Division of Microbiology, National Institute of Health Sciences, Tokyo, Japan

^@ To whom correspondence should be addressed. E-mail: tanamoto{at}nihs.go.jp.

Abstract

MyD88 and IL-1R-associated kinase 1 (IRAK-1) play crucial roles as adaptor molecules in signal transduction of the TLR/IL-1R superfamily, and it is known that expression of these proteins leads to the activation of NF-B in a TNFR-associated factor 6 (TRAF6)-dependent manner. We found in this study, however, that a dominant-negative mutant of TRAF6, lacking the N-terminal RING and zinc-finger domain, did not inhibit IRAK-1-induced activation of NF-B in human embryo kidney 293 cells, although the TRAF6 mutant strongly suppressed the MyD88-induced activation. The dominant-negative mutant of TRAF6 did not affect the IRAK-1-induced activation, regardless of the expression level of IRAK-1. In contrast, small interfering RNA silencing of TRAF6 expression inhibited MyD88-induced and IRAK-1-induced activation, and supplementation with the TRAF6 dominant-negative mutant did not restore the IRAK-1-induced activation. Expression of IRAK-1, but not MyD88, induced the oligomerization of TRAF6, and IRAK-1 and the TRAF6 dominant-negative mutant were associated with TRAF6. These results indicate that TRAF6 is involved but with different mechanisms in MyD88-induced and IRAK-induced activation of NF-B and suggest that TRAF6 uses a distinctive mechanism to activate NF-B depending on signals.

Key Words: Toll-like receptor • IL-1 receptor • lipopolysaccharide

This article has been cited by other articles:

				M. Torroella-Kouri, R. Silvera, D. Rodriguez, R. Caso, A. Shatry, S. Opiela, D. Ilkovitch, R. A. Schwendener, V. Iragavarapu-Charyulu, Y. Cardentey, et al. Identification of a Subpopulation of Macrophages in Mammary Tumor-Bearing Mice That Are Neither M1 nor M2 and Are Less Differentiated Cancer Res., June 1, 2009; 69(11): 4800 - 4809. [Abstract] [Full Text] [PDF]